// App-Quantinova.ai

3441 : Associations between lipopolysaccharide (LPS) and LPS pathway biomarkers and gallbladder cancer are modulated by markers of systemic inflammation

Researchers

Presenter

  • Alison L. Van Dyke

Principal Investigators

  • Troy J. Kemp

  • Amanda F. Corbel

  • Bin Zhu

  • Yu-Tang Gao

  • Bingsheng Wang

  • Asif Rashid

  • Ming-Chang Shen

  • Allan Hildesheim

  • Ann W. Hsing

  • Ligia A. Pinto

  • Jill Koshiol

Medical Centers

  • National Cancer Institute, Rockville, MD

  • Leidos Biomedical Research, Frederick, MD

  • Shanghai Cancer Institute, Shanghai, China

  • Zhongshan Hospital, Fudan University, Department of General Surgery, Shanghai, China

  • 1.MD Anderson Cancer Center, Houston, TX

  • Shanghai Cancer Center, Fudan University, Shanghai, China

  • Stanford University Hospital, Stanford, CA

Locations

  • United States

  • China

Companies

  • Leidos Biomedical Re

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Systemic inflammation

  • Gallbladder cancer

  • Gallbladder disease

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 14

  • Lipopolysaccharide-binding protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved